US 9,987,520

Application 14/671,216 · Granted Jun 5, 2018

Method and system for monitoring and feed-backing on execution of physical exercise routines

Estimated expiration

January 26, 2032

5y 66d remaining

Confidence: medium
Medium: a terminal disclaimer was found but the patents it references could not be read, or several warnings were raised. Read the notes under the details.
Earliest effective filing
Jan 26, 2012
+ 20 years
Jan 26, 2032
PTA +0d
Jan 26, 2032
No TD
—
Final
Jan 26, 2032

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
March 27, 2015
Earliest effective filing
January 26, 2012
Issue date
June 5, 2018
PTA
0 days
Base expiry (before PTA)
January 26, 2032

January 26, 2012 + 20 years = January 26, 2032

  • Continuation of application 13/359,273, filed Jan 26, 2012, issued as US 9,011,293
  • PRO61/436,402 — Provisional — not used for base term
  • PRO61/436,402 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 2 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 14/671,216 · US 9,987,520

PatentReply compiles the prosecution history behind US 9,987,520: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US9987520

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.